📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism. (2024)

First Author: Kavanagh ME

Attributed to: Construction of potent and specific inhibitors of M. tuberculosis redox enzymes using fragment screening methods funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.10.28.620643

PubMed Identifier: 39803573

Publication URI: http://europepmc.org/abstract/MED/39803573

Type: Journal Article/Review

Parent Publication: bioRxiv : the preprint server for biology

ISSN: 2692-8205